No clinical basis for body enhancing usage AOD 9604 'not performance enhancing': Essendon The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York AFL: Essendon Bombers captain Jobe Watson admits using banned substance ABC News AOD 9604 The Fat Burning Peptide: Benefits, Mechanism & Safety